{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:03:06Z","timestamp":1788624186860,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00784-020-03766-8","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T13:03:05Z","timestamp":1609678985000},"page":"4529-4541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study"],"prefix":"10.1007","volume":"25","author":[{"given":"Meltem Ozden","family":"Y\u00fcce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0623-5746","authenticated-orcid":false,"given":"Emine","family":"Adal\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6zde","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"3766_CR1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jcms.2017.05.028","volume":"45","author":"S Aljohani","year":"2017","unstructured":"Aljohani S, Fliefel R, Ihbe J, K\u00fchnisch J, Ehrenfeld M, Otto S (2017) What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a systematic review. J Cranio-Maxillofac Surg 45:1493\u20131502. https:\/\/doi.org\/10.1016\/j.jcms.2017.05.028","journal-title":"J Cranio-Maxillofac Surg"},{"key":"3766_CR2","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jcms.2018.05.003","volume":"46","author":"M Nisi","year":"2018","unstructured":"Nisi M, Karapetsa D, Gennai S, Ramaglia L, Graziani F, Gabriele M (2018) Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up. J Cranio-Maxillofac Surg 46:1153\u20131158. https:\/\/doi.org\/10.1016\/j.jcms.2018.05.003","journal-title":"J Cranio-Maxillofac Surg"},{"key":"3766_CR3","doi-asserted-by":"publisher","unstructured":"Sarkarat F, Motamedi MHK, Jahanbani J, Sepehri D, Kahali R, Nematollahi Z (2014) Platelet-rich plasma in treatment of zoledronic acid-induced bisphosphonate-related osteonecrosis of the jaws. Trauma Mon 19(2). https:\/\/doi.org\/10.5812\/traumamon.17196","DOI":"10.5812\/traumamon.17196"},{"issue":"7","key":"3766_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jcms.2015.04.026","volume":"43","author":"P Barba-Recreo","year":"2015","unstructured":"Barba-Recreo P, Georgiev-Hristov T, Bravo-Burguillos ER, Abarrategi A, Burgue\u00f1o M, Garc\u00eda-Arranz M (2015) Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model. J Cranio-Maxillofac Surg 43(7):1161\u20131168. https:\/\/doi.org\/10.1016\/j.jcms.2015.04.026","journal-title":"J Cranio-Maxillofac Surg"},{"key":"3766_CR5","doi-asserted-by":"publisher","unstructured":"Obinata K, Shirai S, Ito H, Nakamura M, Carrozzo M, Macleod I, Carr A, Yamazaki Y, Tei K (2017) Image findings of bisphosphonate related osteonecrosis of jaws comparing with osteoradionecrosis. Dentomaxillofac Radiol 46(5). https:\/\/doi.org\/10.1259\/dmfr.20160281","DOI":"10.1259\/dmfr.20160281"},{"key":"3766_CR6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F (2014) American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72:1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"3766_CR7","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.ijom.2016.04.010","volume":"45","author":"SE N\u00f8rholt","year":"2016","unstructured":"N\u00f8rholt SE, Hartlev J (2016) Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: a prospective study of 15 patients. Int J Oral Maxillofac Surg 45(10):1256\u20131260. https:\/\/doi.org\/10.1016\/j.ijom.2016.04.010","journal-title":"Int J Oral Maxillofac Surg"},{"key":"3766_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jfma.2015.10.005","volume":"115","author":"LL Tsai","year":"2016","unstructured":"Tsai LL, Huang YF, Chang YC (2016) Treatment of bisphosphonate-related osteonecrosis of the jaw with platelet-rich fibrin. J Formos Med Assoc 115:585\u2013586. https:\/\/doi.org\/10.1016\/j.jfma.2015.10.005","journal-title":"J Formos Med Assoc"},{"key":"3766_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","volume":"16","author":"RA Miksad","year":"2011","unstructured":"Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS (2011) Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 16:121\u2013132. https:\/\/doi.org\/10.1634\/theoncologist.2010-0183","journal-title":"Oncologist"},{"key":"3766_CR10","doi-asserted-by":"publisher","first-page":"3982540","DOI":"10.1155\/2018\/3982540","volume":"2018","author":"R Mauceri","year":"2018","unstructured":"Mauceri R, Panzarella V, Maniscalco L, Bedogni A, Licata ME, Albanese A, Toia F, Cumbo EMG, Mazzola G, di Fede O, Campisi G (2018) Conservative surgical treatment of bisphosphonate-related osteonecrosis of the jaw with Er, Cr: YSGG laser and platelet-rich plasma: a longitudinal study. Biomed Res Int 2018:3982540. https:\/\/doi.org\/10.1155\/2018\/3982540","journal-title":"Biomed Res Int"},{"issue":"5","key":"3766_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/ID.0b013e31822f7a70","volume":"20","author":"DS Sohn","year":"2011","unstructured":"Sohn DS, Heo JU, Kwak DH, Kim DE Kim JM, Moon JW, Lee JH, Park IS (2011) Bone regeneration in the maxillary sinus using an autologous fibrin-rich block with concentrated growth factors alone. Implant Dent 20(5):389\u2013395. https:\/\/doi.org\/10.1097\/ID.0b013e31822f7a70","journal-title":"Implant Dent"},{"issue":"12","key":"3766_CR12","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.joms.2016.06.183","volume":"74","author":"SL Lin","year":"2016","unstructured":"Lin SL, Wu SL, Tsai CC, Ko SY, Chiang WF, Yang JW (2016) The use of solid-phase concentrated growth factors for surgical defects in the treatment of dysplastic lesions of the oral mucosa. J Oral Maxillofac Surg 74(12):2549\u20132556. https:\/\/doi.org\/10.1016\/j.joms.2016.06.183","journal-title":"J Oral Maxillofac Surg"},{"key":"3766_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","volume":"22","author":"L Ramaglia","year":"2018","unstructured":"Ramaglia L, Guida A, Iorio-Siciliano V, Cuozzo A, Blasi A, Sculean A (2018) Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol. Clin Oral Investig 22:597\u2013615. https:\/\/doi.org\/10.1007\/s00784-017-2325-6","journal-title":"Clin Oral Investig"},{"issue":"7","key":"3766_CR14","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.joms.2015.01.008","volume":"73","author":"RN Lopes","year":"2015","unstructured":"Lopes RN, Rabelo GD, Rocha AC (2015) Surgical therapy for bisphosphonate-related osteonecrosis of the jaw: six year experience of a single institution. J Oral Maxillofac Surg 73(7):1288\u20131295. https:\/\/doi.org\/10.1016\/j.joms.2015.01.008","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"3766_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.oooo.2015.10.033","volume":"121","author":"JP Bodem","year":"2016","unstructured":"Bodem JP, Schaal C, Kargus S (2016) Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 121(4):367\u2013372. https:\/\/doi.org\/10.1016\/j.oooo.2015.10.033","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"3766_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","volume":"111","author":"F Wilde","year":"2011","unstructured":"Wilde F, Heufelder M, Winter K (2011) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111(2):153\u2013163. https:\/\/doi.org\/10.1016\/j.tripleo.2010.04.015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"3766_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijom.2016.10.008","volume":"46","author":"O Ristow","year":"2017","unstructured":"Ristow O, Otto S, GeiB C et al (2017) Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study. Int J Oral Maxillofac Surg 46:157\u2013166. https:\/\/doi.org\/10.1016\/j.ijom.2016.10.008","journal-title":"Int J Oral Maxillofac Surg"},{"key":"3766_CR18","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.joms.2016.12.005","volume":"75","author":"JH Park","year":"2017","unstructured":"Park JH, Kim JW, Kim SJ (2017) Does the addition of bone morphogenetic protein 2 to platelet-rich fibrin improve healing after treatment for medication-related osteonecrosis of the jaw? J Oral Maxillofac Surg 75:1176\u20131184. https:\/\/doi.org\/10.1016\/j.joms.2016.12.005","journal-title":"J Oral Maxillofac Surg"},{"key":"3766_CR19","doi-asserted-by":"publisher","unstructured":"Ustaoglu G, Bulut DG, G\u00fcm\u00fcs KC (2019) Evaluation of different platelet-rich concentrates effects on early soft tissue healing and socket preservation after tooth extraction. J Stomatol Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.jormas.2019.09.005","DOI":"10.1016\/j.jormas.2019.09.005"},{"key":"3766_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bone.2014.12.021","volume":"73","author":"T Ikeda","year":"2015","unstructured":"Ikeda T, Kuraguchi J, Kogashiwa Y, Yokoi H, Satomi T, Kohno N (2015) Successful treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) patients with sitafloxacin: new strategies for the treatment of BRONJ. Bone 73:217\u2013222. https:\/\/doi.org\/10.1016\/j.bone.2014.12.021","journal-title":"Bone"},{"issue":"11","key":"3766_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jnci\/djh141","volume":"96","author":"F Saad","year":"2004","unstructured":"Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Zheng M, Zoledronic Acid Prostate Cancer Study Group (2004) Zoledronic acid prostate cancer study group. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96(11):879\u2013882. https:\/\/doi.org\/10.1093\/jnci\/djh141","journal-title":"J Natl Cancer Inst"},{"key":"3766_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415\u2013423. https:\/\/doi.org\/10.1016\/j.joms.2006.10.061","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"3766_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.4317\/medoral.22133","volume":"22","author":"L Bagan","year":"2007","unstructured":"Bagan L, Jim\u00e9nez Y, Leopoldo M, Murillo-Cortes J, Bagan J (2007) Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: associated clinical characteristics. Med Oral Patol Oral Cir Bucal 22(5):582. https:\/\/doi.org\/10.4317\/medoral.22133","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"3766_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.joms.2009.01.003","volume":"67","author":"LA Assael","year":"2009","unstructured":"Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67:35\u201343. https:\/\/doi.org\/10.1016\/j.joms.2009.01.003","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"3766_CR25","first-page":"825","volume":"59","author":"HC M\u00e2nea","year":"2018","unstructured":"M\u00e2nea HC, Urechescu HC, Balica NC et al (2018) Bisphosphonates-induced osteonecrosis of the jaw\u2013epidemiological, clinical and histopathological aspects. Romanian J Morphol Embryol 59(3):825\u2013831","journal-title":"Romanian J Morphol Embryol"},{"key":"3766_CR26","doi-asserted-by":"publisher","unstructured":"Marx RE (2009) Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws J Oral Maxillofac Surg 67(5): 107\u2013119. https:\/\/doi.org\/10.1016\/j.joms.2008.12.007","DOI":"10.1016\/j.joms.2008.12.007"},{"key":"3766_CR27","unstructured":"British Dental Association, Bisphosphonates Fact File, British Dental Association, London, 2008"},{"issue":"1","key":"3766_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2014.10.015","volume":"51","author":"M Del Fabbro","year":"2015","unstructured":"Del Fabbro M, Gallesio G, Mozzati M (2015) Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. Eur J Cancer 51(1):62\u201374. https:\/\/doi.org\/10.1016\/j.ejca.2014.10.015","journal-title":"Eur J Cancer"},{"key":"3766_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1302\/0301-620X.89B3.18491","volume":"89","author":"TM Bielecki","year":"2007","unstructured":"Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Kr\u00f2l W, Wielkoszynski T (2007) Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Joint Surg (Br) 89:417\u2013420. https:\/\/doi.org\/10.1302\/0301-620X.89B3.18491","journal-title":"J Bone Joint Surg (Br)"},{"issue":"1","key":"3766_CR30","first-page":"50","volume":"4","author":"VP Waiker","year":"2015","unstructured":"Waiker VP, Shivalingappa S (2015) Comparison between conventional mechanical fixation and use of autologous platelet rich plasma (PRP) in wound beds prior to resurfacing with split thickness skin graft. World J Plastic Surg 4(1):50 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25606477","journal-title":"World J Plastic Surg"},{"issue":"9","key":"3766_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.oraloncology.2012.03.009","volume":"48","author":"M Mozzati","year":"2012","unstructured":"Mozzati M, Arata V, Gallesio G (2012) Tooth extraction in patients on zoledronic acid therapy. Oral Oncol 48(9):817\u2013821. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.03.009","journal-title":"Oral Oncol"},{"issue":"1","key":"3766_CR32","first-page":"151","volume":"26","author":"V Coviello","year":"2012","unstructured":"Coviello V, Peluso F, Dehkhargani SZ, Verdugo F, Raffaelli LUCA, Manicone PF (2012) Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients. J Biol Regul Homeost Agents 26(1):151\u2013155","journal-title":"J Biol Regul Homeost Agents"},{"key":"3766_CR33","doi-asserted-by":"publisher","first-page":"298945","DOI":"10.1155\/2014\/298945","volume":"2014","author":"F Longo","year":"2014","unstructured":"Longo F, Guida A, Aversa C, Pavone E, Di Costanzo G, Ramaglia L, Ionna F (2014) Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent 2014:298945. https:\/\/doi.org\/10.1155\/2014\/298945","journal-title":"Int J Dent"},{"issue":"9","key":"3766_CR34","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","volume":"52","author":"JW Kim","year":"2014","unstructured":"Kim JW, Kim SJ, Kim MR (2014) Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study. Brit J Oral Maxillofac Surg 52(9):854\u2013859. https:\/\/doi.org\/10.1016\/j.bjoms.2014.07.256","journal-title":"Brit J Oral Maxillofac Surg"},{"issue":"2","key":"3766_CR35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3892\/mmr.2018.9714","volume":"19","author":"X Li","year":"2019","unstructured":"Li X, Yang H, Zhang Z, Yan Z, Lv H, Zhang Y, Wu B (2019) Concentrated growth factor exudate enhances the proliferation of human periodontal ligament cells in the presence of TNF-\u03b1. Mol Med Rep 19(2):943\u2013950. https:\/\/doi.org\/10.3892\/mmr.2018.9714","journal-title":"Mol Med Rep"},{"key":"3766_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4597321","volume":"2018","author":"E Borsani","year":"2018","unstructured":"Borsani E, Bonazza V, Buffoli B et al (2018) Beneficial effects of concentrated growth factors and resveratrol on human osteoblasts in vitro treated with bisphosphonates. Biomed Res Int 2018:1\u201313. https:\/\/doi.org\/10.1155\/2018\/4597321","journal-title":"Biomed Res Int"},{"issue":"4","key":"3766_CR37","doi-asserted-by":"publisher","first-page":"FS136","DOI":"10.4155\/fsoa-2016-0019","volume":"2","author":"J Qiao","year":"2016","unstructured":"Qiao J, Duan J, Zhang Y, Chu Y, Sun C (2016) The effect of concentrated growth factors in the treatment of periodontal intrabony defects. Future Sci OA 2(4):FS136. https:\/\/doi.org\/10.4155\/fsoa-2016-0019","journal-title":"Future Sci OA"},{"issue":"9","key":"3766_CR38","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/jcpe.12444","volume":"42","author":"S Bozkurt Dogan","year":"2015","unstructured":"Bozkurt Dogan S, Ongoz Dede F, Balli U, Atalay EN, Durmuslar MC (2015) Concentrated growth factor in the treatment of adjacent multiple gingival recessions: a Split-mouth randomized clinical trial. J Clin Periodontol 42(9):868\u2013875. https:\/\/doi.org\/10.1111\/jcpe.12444","journal-title":"J Clin Periodontol"},{"key":"3766_CR39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/jemt.20968","volume":"74","author":"LF Rodella","year":"2011","unstructured":"Rodella LF, Favero G, Boninsegna R, Buffoli B, Labanca M, Scari G, Sacco L, Batani T, Rezzani R (2011) Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fraction. Microsc Res Tech 74:772\u2013777. https:\/\/doi.org\/10.1002\/jemt.20968","journal-title":"Microsc Res Tech"},{"key":"3766_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.archoralbio.2014.02.004","volume":"59","author":"TH Kim","year":"2014","unstructured":"Kim TH, Kim SH, Sandor GK, Kim YD (2014) Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol 59:550\u2013558. https:\/\/doi.org\/10.1016\/j.archoralbio.2014.02.004","journal-title":"Arch Oral Biol"},{"key":"3766_CR41","doi-asserted-by":"publisher","first-page":"27348","DOI":"10.1038\/srep27348","volume":"6","author":"Y Chen","year":"2016","unstructured":"Chen Y, Cai Z, Zheng D, Lin P, Cai Y, Hong S, Lai Y, Wu D (2016) Inlay osteotome sinus floor elevation with concentrated growth factor application and simultaneous short implant placement in severely atrophic maxilla. Sci Rep 6:27348. https:\/\/doi.org\/10.1038\/srep27348","journal-title":"Sci Rep"},{"key":"3766_CR42","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1902\/jop.2014.130740","volume":"85","author":"YS Choi","year":"2014","unstructured":"Choi YS, Kim YC, Ji S, Choi Y (2014) Increased bacterial invasion and differential expression of tight-junction proteins, growth factors, and growth factor receptors in periodontal lesions. J Periodontol 85:e313\u2013e322. https:\/\/doi.org\/10.1902\/jop.2014.130740","journal-title":"J Periodontol"},{"key":"3766_CR43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.5999\/aps.2013.40.5.530","volume":"40","author":"JW Lee","year":"2013","unstructured":"Lee JW, Kwon OH, Kim TK, Cho YK, Choi KY, Chung HY, Cho BC, Yang JD, Shin CH (2013) Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg 40:530\u2013535. https:\/\/doi.org\/10.5999\/aps.2013.40.5.530","journal-title":"Arch Plast Surg"},{"key":"3766_CR44","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.tripleo.2005.07.009","volume":"101","author":"DM Dohan","year":"2006","unstructured":"Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:e45\u2013e50. https:\/\/doi.org\/10.1016\/j.tripleo.2005.07.009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"3766_CR45","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1080\/09537104.2016.1267338","volume":"28","author":"J Qiao","year":"2017","unstructured":"Qiao J, An N, Quyang X (2017) Quantification of growth factors in different platelet concentrates. Platelets 28:774\u2013778. https:\/\/doi.org\/10.1080\/09537104.2016.1267338","journal-title":"Platelets"},{"key":"3766_CR46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3892\/ijmm.2016.2520","volume":"37","author":"J Qin","year":"2016","unstructured":"Qin J, Wang L, Zheng L, Zhou X, Zhang Y, Yang T, Zhou Y (2016) Concentrated growth factor promotes Schwann cell migration partly through the integrin b1-mediated activation of the focal adhesion kinase pathway. Int J Mol Med 37:1363\u20131370. https:\/\/doi.org\/10.3892\/ijmm.2016.2520","journal-title":"Int J Mol Med"},{"issue":"4","key":"3766_CR47","doi-asserted-by":"publisher","first-page":"e12458","DOI":"10.1111\/jicd.12458","volume":"10","author":"A Takahashi","year":"2019","unstructured":"Takahashi A, Tsujino T, Yamaguchi S, Isobe K, Watanabe T, Kitamura Y, Okuda K, Nakata K, Kawase T (2019) Distribution of platelets, transforming growth factor-\u03b21, platelet-derived growth factor-BB, vascular endothelial growth factor and matrix metalloprotease-9 in advanced platelet-rich fibrin and concentrated growth factor matrices. J Investig Clin Dent 10(4):e12458. https:\/\/doi.org\/10.1111\/jicd.12458","journal-title":"J Investig Clin Dent"},{"key":"3766_CR48","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.oooo.2016.03.008","volume":"122","author":"SEC Pichardo","year":"2016","unstructured":"Pichardo SEC, van Merkesteyn RJP (2016) Evaluation of a surgical treatment of denosumab-related osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol 122:272\u2013278. https:\/\/doi.org\/10.1016\/j.oooo.2016.03.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"3766_CR49","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/adj.12217","volume":"59","author":"M O\u2019Halloran","year":"2014","unstructured":"O\u2019Halloran M, Boyd NM, Smith A (2014) Denosumab and osteonecrosis of the jaws \u2013 the pharmacology, pathogenesis and a report of two cases. Aust Dent J 59:516\u2013519. https:\/\/doi.org\/10.1111\/adj.12217","journal-title":"Aust Dent J"},{"key":"3766_CR50","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/jcpe.12882","volume":"45","author":"M Diniz-Freitas","year":"2018","unstructured":"Diniz-Freitas M, Fernandez-Feijoo J, Dios PD, Pousa X, Limeras J (2018) Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: a case report. J Clin Periodontol 45:570\u2013577. https:\/\/doi.org\/10.1111\/jcpe.12882","journal-title":"J Clin Periodontol"},{"key":"3766_CR51","doi-asserted-by":"publisher","first-page":"625","DOI":"10.12688\/f1000research.10682.1","volume":"6","author":"S Fukumoto","year":"2017","unstructured":"Fukumoto S, Matsumoto T (2017) Recent advances in the management of osteoporosis. F1000Res 6:625. https:\/\/doi.org\/10.12688\/f1000research.10682.1","journal-title":"F1000Res"},{"key":"3766_CR52","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/j.oooo.2012.01.046","volume":"116","author":"MS Epstein","year":"2013","unstructured":"Epstein MS, Ephros HD, Epstein JB (2013) Review of current literature and implications of RANKL inhibitors for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol 116:e437\u2013e442. https:\/\/doi.org\/10.1016\/j.oooo.2012.01.046","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"3766_CR53","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/sj.bdj.2014.811","volume":"217","author":"A Robinson","year":"2014","unstructured":"Robinson A, Scully C (2014) Pharmacology: new therapies and challenges. Br Dent J 217:258\u2013259. https:\/\/doi.org\/10.1038\/sj.bdj.2014.811","journal-title":"Br Dent J"},{"issue":"8","key":"3766_CR54","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","volume":"28","author":"T Hasegawa","year":"2017","unstructured":"Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M et al (2017) A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos Int 28(8):2465\u20132473. https:\/\/doi.org\/10.1007\/s00198-017-4063-7","journal-title":"Osteoporos Int"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-020-03766-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T01:06:43Z","timestamp":1627088803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-020-03766-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3766"],"URL":"https:\/\/doi.org\/10.1007\/s00784-020-03766-8","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"28 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (15-12.1\/10) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}